Yep. I don't doubt it. It's just not coming across in the announcements.
How can a phase 3 oncology pharma with very strong indications of also having therapeutic effect have a MC of less than 30M?
Answer - delays and poor communications.
- Forums
- ASX - By Stock
- PAA
- Ann: Shareholder Update - Progress and Strategy
Ann: Shareholder Update - Progress and Strategy, page-30
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $85.12M |
Open | High | Low | Value | Volume |
18.0¢ | 18.5¢ | 17.5¢ | $59.53K | 337.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 518045 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 34777 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35000 | 0.180 |
10 | 518045 | 0.175 |
9 | 509842 | 0.170 |
5 | 157060 | 0.165 |
9 | 476304 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 32105 | 2 |
0.180 | 114777 | 3 |
0.185 | 427553 | 5 |
0.190 | 412322 | 5 |
0.195 | 750282 | 11 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |